What is the brand name for guaifenesin phenylpropanolamine hydrochloride chlorpheniramine maleate?
•
4 min read
In 2000, the U.S. Food and Drug Administration (FDA) issued a public health warning regarding products containing phenylpropanolamine (PPA) due to an increased risk of hemorrhagic stroke. For this reason, the specific combination of **guaifenesin phenylpropanolamine hydrochloride chlorpheniramine maleate** is not available on the U.S. market under any brand name, although it may still be found in some other countries.